Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both?
Publication
, Journal Article
Glass, LM; Hunt, CM; Fuchs, M; Su, GL
Published in: Fed Pract
February 2019
Improvement in NAFLD may lead to improvement of metabolic syndrome, cardiovascular disease, and malignancy and vice versa.
Duke Scholars
Published In
Fed Pract
ISSN
1078-4497
Publication Date
February 2019
Volume
36
Issue
2
Start / End Page
64 / 71
Location
United States
Citation
APA
Chicago
ICMJE
MLA
NLM
Glass, L. M., Hunt, C. M., Fuchs, M., & Su, G. L. (2019). Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both? Fed Pract, 36(2), 64–71.
Glass, Lisa M., Christine M. Hunt, Michael Fuchs, and Grace L. Su. “Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both?” Fed Pract 36, no. 2 (February 2019): 64–71.
Glass LM, Hunt CM, Fuchs M, Su GL. Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both? Fed Pract. 2019 Feb;36(2):64–71.
Glass, Lisa M., et al. “Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both?” Fed Pract, vol. 36, no. 2, Feb. 2019, pp. 64–71.
Glass LM, Hunt CM, Fuchs M, Su GL. Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both? Fed Pract. 2019 Feb;36(2):64–71.
Published In
Fed Pract
ISSN
1078-4497
Publication Date
February 2019
Volume
36
Issue
2
Start / End Page
64 / 71
Location
United States